Essex LLC Pfizer Inc Transaction History

Essex LLC

$482 Million
Q3 2024

A detailed history of Essex LLC transactions in Pfizer Inc stock. As of the latest transaction made, Essex LLC holds 77,165 shares of PFE stock, worth $2.06 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

77,165

Previous 77,078 0.11%

Holding current value

$2.06 Million

Previous $2.16 Million 3.57%

% of portfolio

0.46%

Previous 0.49%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$27.7 - $31.39 $2,409 - $2,730	87 Added 0.11%	77,165 $2.23 Million
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $33,343 - $39,072	1,320 Added 1.74%	77,078 $2.16 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $129 - $148	-5 Reduced 0.01%	75,758 $2.1 Million
Q4 2023 Jan 29, 2024	BUY	$26.13 - $33.94 $254,741 - $330,881	9,749 Added 14.77%	75,763 $2.18 Million
Q3 2023 Oct 16, 2023	BUY	$32.09 - $37.51 $298,051 - $348,392	9,288 Added 16.37%	66,014 $2.19 Million
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $325,477 - $376,569	-9,011 Reduced 13.71%	56,726 $2.08 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $52,521 - $68,561	1,258 Added 1.95%	65,737 $3.37 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $47,348 - $57,800	-1,082 Reduced 1.65%	64,479 $2.82 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $57,324 - $67,969	1,232 Added 1.92%	65,561 $3.44 Million
Q1 2022 Apr 20, 2022	BUY	$45.75 - $56.69 $451,735 - $559,757	9,874 Added 18.13%	64,329 $3.33 Million
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $399,440 - $592,103	9,667 Added 21.58%	54,455 $3.22 Million
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $1.76 Million - $2.26 Million	44,788 New	44,788 $1.93 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.

Account